Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIVIRON: Ferric Carboxymaltose in Orthopedic Surgery
NCT01345968Phase 4Terminated
- Sponsor
- Universitätsklinikum Münster
- Start
- Jun 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferric carboxymaltose in anemia, sponsored by Universitätsklinikum Münster. Started Jun 2011; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01345968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345968.